NIAID strives to promote diversity at every stage of biomedical research training, from high school to postdoctoral trainees. The primary goal is to engage and recruit trainees from populations underrepresented in biomedical research — which includes individuals from underrepresented racial and ethnic groups, those with disabilities, and those from disadvantaged backgrounds — as defined by NIH’s Interest in Diversity Notice. The training office also works to develop new opportunities that will enhance recruiting and retention, and to generate diversity awareness across the institute.
For more information, refer to the following:
- Scientific Workforce Diversity (SWD) Office
- Office of Equity, Diversity, and Inclusion
- Diversity in Extramural Programs
Why Train at NIAID?
Many questions still have no answer about the epidemiology and the ecology of plague in Madagascar. After my Ph.D., I wanted to go further into the comprehension of plague transmission ecology. I’m most interested in the interaction between plague bacterium and vector fleas. The laboratory of Joe Hinnebusch, Ph.D., at the Rocky Mountain Laboratories (RML) is amongst few institutions performing outstanding research focusing on the genetic and molecular processes of plague transmission, infection, and immunity. I knew the research group from their noteworthy scientific publications. Then I decided to contact Dr. Hinnebusch about the possibility for me to get a postdoctoral position in his lab, working on topics related to flea transmission of Y. pestis. This is how I got involved in the research group. I’m currently working, amongst other things, on vector capacity of flea species.
Moving to a new country, adopting a new language, and exploring a new scientific domain was challenging. Joining an NIH research group at RML is, of course, a valuable experience for my career, but also for my personal development. My training at the NIH will open new perspectives related to fleaborne transmission of plague, for a better understanding of Madagascar plague ecology and transmission. So far, addressing those questions may help the implementation of more adapted strategies to protect people against the disease.” - Adelaide Miarinjara, Ph.D.